Tag: safety
Novartis, stressing Beovu safety, matches Eylea in head-to-head diabetic macular edema...
Novartis is aiming its new eye drug Beovu, a challenger to Regeneron's Eylea, at another of its rival's key markets. And amid a raft...
Lilly, Boehringer hit heart safety mark with Januvia rival Tradjenta. Is...
Boehringer Ingelheim and Eli Lilly’s Tradjenta is working to pick up share in an ultracompetitive diabetes market, and it’s hoping some new outcomes data...